• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不止是如出一辙:神经退行性疾病中tau蛋白和α-突触核蛋白的共同淀粉样变性特性

More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.

作者信息

Lee Virginia M-Y, Giasson Benoit I, Trojanowski John Q

机构信息

The Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, and Institute on Aging, the University of Pennsylvania, Philadelphia, PA 19104-4283, USA.

出版信息

Trends Neurosci. 2004 Mar;27(3):129-34. doi: 10.1016/j.tins.2004.01.007.

DOI:10.1016/j.tins.2004.01.007
PMID:15036877
Abstract

Intracytoplasmic filamentous aggregates, such as neurofibrillary tangles in Alzheimer's disease and Lewy bodies in Parkinson's disease, are composed of the proteins tau and alpha-synuclein, respectively. These pathological inclusions are linked directly to the etiology and mechanisms of disease in a wide spectrum of neurodegenerative disorders, termed 'tauopathies' and 'synucleinopathies'. Emerging evidence indicates that there is frequent overlap of the pathological and clinical features of patients with tauopathies and synucleinopathies, thereby re-enforcing the notion that these disorders might be linked mechanistically. Indeed, several lines of investigation suggest that tau and alpha-synuclein might constitute a unique class of unstructured proteins that assemble predominantly into homopolymeric (rather than heteropolymeric) fibrils, which deposit mainly in separate amyloid inclusions, but occasionally deposit together. Thus, the ability of tau and alpha-synuclein to affect each other directly or indirectly might contribute to the overlap in the clinical and pathological features of tauopathies and synucleinopathies.

摘要

胞质内丝状聚集体,如阿尔茨海默病中的神经原纤维缠结和帕金森病中的路易小体,分别由蛋白质tau和α-突触核蛋白组成。这些病理性包涵体与广泛的神经退行性疾病(称为“tau蛋白病”和“突触核蛋白病”)的病因和发病机制直接相关。新出现的证据表明,tau蛋白病和突触核蛋白病患者的病理和临床特征经常重叠,从而强化了这些疾病可能在机制上存在联系的观点。事实上,多项研究表明,tau和α-突触核蛋白可能构成一类独特的无结构蛋白,它们主要组装成同聚物(而非异聚物)纤维,这些纤维主要沉积在单独的淀粉样包涵体中,但偶尔也会一起沉积。因此,tau和α-突触核蛋白直接或间接相互影响的能力可能导致tau蛋白病和突触核蛋白病在临床和病理特征上的重叠。

相似文献

1
More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.不止是如出一辙:神经退行性疾病中tau蛋白和α-突触核蛋白的共同淀粉样变性特性
Trends Neurosci. 2004 Mar;27(3):129-34. doi: 10.1016/j.tins.2004.01.007.
2
Interactions of amyloidogenic proteins.淀粉样蛋白的相互作用。
Neuromolecular Med. 2003;4(1-2):49-58. doi: 10.1385/NMM:4:1-2:49.
3
NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).弥漫性神经原纤维缠结伴钙化(DNTC)中的NACP/α-突触核蛋白免疫反应性。
Acta Neuropathol. 2002 Oct;104(4):333-41. doi: 10.1007/s00401-002-0545-5. Epub 2002 May 8.
4
Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.神经退行性疾病中的丝状神经细胞内含物:tau蛋白病和α-突触核蛋白病。
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1101-18. doi: 10.1098/rstb.1999.0466.
5
Following the leader: fibrillization of alpha-synuclein and tau.跟随引领者:α-突触核蛋白和tau蛋白的纤维化
Exp Neurol. 2004 Jun;187(2):235-9. doi: 10.1016/j.expneurol.2004.02.008.
6
Interface between tauopathies and synucleinopathies: a tale of two proteins.tau 蛋白病与α-突触核蛋白病之间的关联:两种蛋白质的故事
Ann Neurol. 2006 Mar;59(3):449-58. doi: 10.1002/ana.20819.
7
Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.杏仁核中的路易小体:在伴有基于tau蛋白包涵体的神经退行性疾病中α-突触核蛋白聚集体增加。
Arch Neurol. 2004 Dec;61(12):1915-9. doi: 10.1001/archneur.61.12.1915.
8
Initiation and synergistic fibrillization of tau and alpha-synuclein.tau蛋白与α-突触核蛋白的起始及协同纤维化
Science. 2003 Apr 25;300(5619):636-40. doi: 10.1126/science.1082324.
9
Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.由A53Tα-突触核蛋白突变引起的家族性帕金森病中α-突触核蛋白和tau蛋白的纤维化
Exp Neurol. 2004 Jun;187(2):279-88. doi: 10.1016/j.expneurol.2004.01.007.
10
Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation.散发性阿尔茨海默病病例中的α-突触核蛋白阳性结构:形态及其与tau蛋白聚集的关系。
Brain Res. 2001 Jan 12;888(2):287-296. doi: 10.1016/s0006-8993(00)03082-1.

引用本文的文献

1
Alzheimer's disease traits in Parkinson's disease without α-synuclein seeding.无α-突触核蛋白播种的帕金森病中的阿尔茨海默病特征。
Alzheimers Dement. 2025 May;21(5):e70284. doi: 10.1002/alz.70284.
2
Iron-Mediated Overexpression of Amyloid Precursor Protein via Iron Responsive mRNA in Alzheimer's Disease.铁通过铁反应性mRNA介导阿尔茨海默病中淀粉样前体蛋白的过表达。
Int J Mol Sci. 2025 May 30;26(11):5283. doi: 10.3390/ijms26115283.
3
α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies.
α-突触核蛋白与tau蛋白:相互作用、交叉播种以及将突触核蛋白病重新定义为复杂蛋白质病
Front Neurosci. 2025 Mar 27;19:1570553. doi: 10.3389/fnins.2025.1570553. eCollection 2025.
4
Targeting Iron Responsive Elements (IREs) of APP mRNA into Novel Therapeutics to Control the Translation of Amyloid-β Precursor Protein in Alzheimer's Disease.将APP mRNA的铁反应元件(IREs)作为新型治疗靶点以控制阿尔茨海默病中淀粉样β前体蛋白的翻译
Pharmaceuticals (Basel). 2024 Dec 11;17(12):1669. doi: 10.3390/ph17121669.
5
Amygdala-predominant α-synuclein pathology is associated with exacerbated hippocampal neuron loss in Alzheimer's disease.杏仁核为主的α-突触核蛋白病理学与阿尔茨海默病中海马神经元丢失加剧有关。
Brain Commun. 2024 Dec 5;6(6):fcae442. doi: 10.1093/braincomms/fcae442. eCollection 2024.
6
A systematic review of salivary biomarkers in Parkinson's disease.帕金森病唾液生物标志物的系统评价。
Neural Regen Res. 2024 Dec 1;19(12):2613-2625. doi: 10.4103/NRR.NRR-D-23-01677. Epub 2024 Mar 1.
7
Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration.tau 病和突触核蛋白病之间的重叠和分歧:神经退行性变的二重奏。
Transl Neurodegener. 2024 Mar 26;13(1):16. doi: 10.1186/s40035-024-00407-y.
8
Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease.路易体病和阿尔茨海默病临床病理谱中的 Tau 成熟。
Ann Clin Transl Neurol. 2024 Mar;11(3):673-685. doi: 10.1002/acn3.51988. Epub 2024 Jan 23.
9
Prevalence of Concomitant Pathologies in Parkinson's Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms.帕金森病合并症的患病率:对预后、诊断的影响及对常见致病机制的见解
J Parkinsons Dis. 2024;14(1):35-52. doi: 10.3233/JPD-230154.
10
Iron response elements (IREs)-mRNA of Alzheimer's amyloid precursor protein binding to iron regulatory protein (IRP1): a combined molecular docking and spectroscopic approach.铁反应元件 (IRE)-阿尔茨海默病淀粉样前体蛋白结合铁调节蛋白 (IRP1)的 mRNA:一种联合分子对接和光谱方法。
Sci Rep. 2023 Mar 28;13(1):5073. doi: 10.1038/s41598-023-32073-x.